Adalimumab (Humira)

Rheumatology (TNF-alpha Inhibitor)

Dosing & Administration

Adult Dose

40 mg SC every other week.

Pediatric Dose

Weight-based SC every other week (e.g., JIA).

Renal Adjustment

No adjustment necessary.

Hepatic Adjustment

No adjustment necessary.

Safety & Special Populations

Pregnancy Category

B

Lactation Safety

Compatible.

Contraindications & Adverse Effects

Contraindications

  • Active severe infections (e.g., Tuberculosis)

Common Adverse Effects

  • Injection site reactions
  • Immunosuppression (risk of TB, fungal infections)
  • Drug-induced lupus